← Evidence map

ArticleNature reviews. Rheumatology2026

Engineered sialylated IgG1 Fc as a dose-sparing alternative to IVIG.

Sruthi Vijaya Retnakumar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41491288